Ferroptosis plays a vital role in clinical tumour drug resistance, and its inhibitor solute carrier family 7 member 11 (SLC7A11) is a promising target to overcome resistance in conventional cancer therapy. The gene discussed is SLC7A11; the disease is cancer.